News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,246 Results
Type
Article (39488)
Company Profile (307)
Press Release (649451)
Section
Business (204991)
Career Advice (2003)
Deals (35504)
Drug Delivery (87)
Drug Development (81049)
Employer Resources (168)
FDA (16150)
Job Trends (14868)
News (346145)
Policy (32578)
Tag
Academia (2552)
Alliances (49511)
Alzheimer's disease (1234)
Approvals (16080)
Artificial intelligence (132)
Bankruptcy (355)
Best Places to Work (11563)
Biotechnology (218)
Breast cancer (123)
Cancer (1085)
Cardiovascular disease (97)
Career advice (1672)
Cell therapy (234)
Clinical research (64409)
Collaboration (391)
Compensation (197)
COVID-19 (2548)
C-suite (95)
Data (1120)
Diabetes (154)
Diagnostics (6175)
Earnings (84970)
Employer resources (146)
Events (110083)
Executive appointments (310)
FDA (16688)
Funding (353)
Gene therapy (177)
GLP-1 (582)
Government (4340)
Healthcare (18713)
Infectious disease (2633)
Inflammatory bowel disease (110)
Interviews (308)
IPO (16338)
Job creations (3661)
Job search strategy (1429)
Layoffs (418)
Legal (7891)
Lung cancer (170)
Manufacturing (177)
Medical device (13223)
Medtech (13228)
Mergers & acquisitions (19238)
Metabolic disorders (409)
Neuroscience (1511)
NextGen Class of 2024 (6546)
Non-profit (4482)
Northern California (1480)
Obesity (233)
Opinion (183)
Patents (102)
People (56659)
Phase I (20021)
Phase II (28365)
Phase III (21156)
Pipeline (455)
Postmarket research (2556)
Preclinical (8528)
Radiopharmaceuticals (236)
Rare diseases (219)
Real estate (5947)
Regulatory (21611)
Research institute (2320)
Resumes & cover letters (350)
Southern California (1304)
Startups (3626)
United States (13510)
Vaccines (550)
Weight loss (172)
Date
Today (129)
Last 7 days (806)
Last 30 days (3807)
Last 365 days (35801)
2024 (32833)
2023 (40214)
2022 (51331)
2021 (55881)
2020 (54208)
2019 (46722)
2018 (35171)
2017 (32272)
2016 (31674)
2015 (37761)
2014 (31487)
2013 (26536)
2012 (28799)
2011 (29476)
2010 (27569)
Location
Africa (716)
Arizona (192)
Asia (37434)
Australia (6115)
California (3339)
Canada (1288)
China (248)
Colorado (145)
Connecticut (152)
Europe (80182)
Florida (458)
Georgia (116)
Illinois (344)
Indiana (198)
Kansas (97)
Maryland (577)
Massachusetts (2616)
Michigan (157)
Minnesota (273)
New Jersey (952)
New York (958)
North Carolina (706)
Northern California (1480)
Ohio (141)
Pennsylvania (845)
South America (1095)
Southern California (1304)
Texas (464)
Utah (90)
Washington State (361)
689,246 Results for "flagship biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Flagship’s AI Company Generate Inks Deal Worth up to $1B With Novartis
Flagship Pioneering–backed Generate:Biomedicines has signed its second major Big Pharma partnership, bringing in $65 million upfront to use its AI platform to discover novel protein drug candidates.
September 24, 2024
·
2 min read
·
Annalee Armstrong
Collaboration
Pfizer Partners With Flagship’s Quotient to Leverage Genetics Against Heart, Renal Diseases
Quotient Therapeutics’ platform targets somatic mutations, which the startup contends can help identify a broader scope of genes potentially associated with disease phenotypes. Wednesday’s agreement is part of an existing partnership between Pfizer and Flagship Pioneering.
August 28, 2024
·
2 min read
·
Tristan Manalac
Business
GSK, Flagship Commit $150M Upfront for Initial Development of Respiratory, Immunology Programs
Flagship Pioneering and its portfolio companies are in line to receive up to $720 million in milestones for each of the 10 programs that GSK could option, according to Monday’s announcement.
July 30, 2024
·
2 min read
·
Nick Paul Taylor
Press Releases
Somite Therapeutics and OmniaBio Inc. Announce Collaboration to Advance Somite’s Cell Therapy Flagship Program
September 9, 2024
·
5 min read
Business
Pfizer, Flagship Pioneering to Target Obesity Treatments Under 2023 Partnership
Building on last year’s potential $7 billion partnership with Flagship Pioneering, Pfizer and Flagship-founded ProFound Therapeutics will work on discovering new obesity candidates.
June 12, 2024
·
2 min read
·
Tyler Patchen
Business
VC Firm Flagship Raises $3.6B to Create, Support 25 ‘Breakthrough’ Companies
Biotech venture capital firm Flagship Pioneering is looking to fund companies focused on artificial intelligence, human health and sustainability, bringing the total raised since 2021 to $6.4 billion.
July 10, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies
November 20, 2024
·
5 min read
Business
Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management
Metaphore Biotechnologies, a Flagship-founded biotechnology company designing novel therapeutics by combining machine learning and molecular mimicry, joined Flagship Pioneering in announcing a research collaboration with Novo Nordisk to develop up to two next-generation therapeutics for obesity management.
May 9, 2024
·
6 min read
Press Releases
A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore
October 3, 2024
·
4 min read
Flagship-Founded Microbiome Company Evelo Biosciences Throws in the Towel
In an SEC filing, the biotech launched by Flagship Pioneering said there was no viable alternative to dissolution as its cash ran out and anti-inflammatory assets failed to achieve clinical success.
November 22, 2023
·
1 min read
·
Kate Goodwin
1 of 68,925
Next
